Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning Balance at Dec. 31, 2022	$ 801,128	$ 3,072	$ 783,579		$ 14,477
Beginning Balance , Shares at Dec. 31, 2022		306,626,530
Stock-based compensation expense	24,001		24,001
Issuance of common stock under employee plans	2,997	$ 4	2,993
Issuance of common stock under employee plans, shares		434,952
Vesting of restricted stock units		$ 7	(7)
Vesting of restricted stock units, Shares		694,100
Exercise of stock options	6,779	$ 74	6,705
Exercise of stock options, shares		7,436,819
Net income	80,130				80,130
Ending Balance at Dec. 31, 2023	915,035	$ 3,157	817,271		94,607
Ending Balance , Shares at Dec. 31, 2023		315,192,401
Stock-based compensation expense	25,563		25,563
Issuance of common stock under employee plans	2,711	$ 4	2,707
Issuance of common stock under employee plans, shares		437,539
Vesting of restricted stock units		$ 13	(13)
Vesting of restricted stock units, Shares		1,390,754
Exercise of stock options	4,139	$ 97	4,042
Exercise of stock options, shares		9,671,863
Tax withholding on option exercises	(19,335)	$ (29)	(19,306)
Tax withholding on option exercises, Shares		(2,998,694)
Net income	70,239				70,239
Ending Balance at Dec. 31, 2024	998,352	$ 3,242	830,264		164,846
Ending Balance , Shares at Dec. 31, 2024		323,693,863
Stock-based compensation expense	26,633		26,633
Issuance of common stock under employee plans	2,375	$ 5	2,370
Issuance of common stock under employee plans, shares		450,746
Vesting of restricted stock units		$ 19	(19)
Vesting of restricted stock units, Shares		1,934,289
Exercise of stock options	$ 2,869	$ 22	2,847
Exercise of stock options, shares	2,203,635	2,203,635
Loss on interest rate swap	$ (293)			$ (293)
Net income	103,077				103,077
Ending Balance at Dec. 31, 2025	$ 1,133,013	$ 3,288	$ 862,095	$ (293)	$ 267,923
Ending Balance , Shares at Dec. 31, 2025		328,282,533